MARCHF7
Basic information
Region (hg38): 2:159712457-159771027
Previous symbols: [ "AXOT", "MARCH7" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (83 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MARCHF7 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001282805.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 80 | 83 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 80 | 3 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MARCHF7 | protein_coding | protein_coding | ENST00000259050 | 9 | 58539 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.662 | 0.338 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.236 | 348 | 361 | 0.965 | 0.0000181 | 4526 |
Missense in Polyphen | 148 | 155.48 | 0.95191 | 1966 | ||
Synonymous | -0.0579 | 133 | 132 | 1.01 | 0.00000664 | 1384 |
Loss of Function | 4.31 | 7 | 34.2 | 0.205 | 0.00000197 | 444 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000107 | 0.000105 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000102 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase which may specifically enhance the E2 activity of HIP2. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates. {ECO:0000269|PubMed:16868077}.;
Recessive Scores
- pRec
- 0.244
Intolerance Scores
- loftool
- 0.472
- rvis_EVS
- 0.73
- rvis_percentile_EVS
- 86.3
Haploinsufficiency Scores
- pHI
- 0.245
- hipred
- Y
- hipred_score
- 0.530
- ghis
- 0.528
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.921
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- March7
- Phenotype
- homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of tolerance induction;positive regulation of cell population proliferation;negative regulation of T cell proliferation;negative regulation of DNA damage response, signal transduction by p53 class mediator;protein stabilization;protein autoubiquitination;negative regulation of proteasomal protein catabolic process;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;positive regulation of protein polyubiquitination;negative regulation of protein autoubiquitination
- Cellular component
- nucleus;cytosol;plasma membrane
- Molecular function
- protein binding;zinc ion binding;transferase activity;ubiquitin conjugating enzyme binding;ubiquitin binding;MDM2/MDM4 family protein binding